검색어 : 통합검색[Carreras José]
총 229건 중 229건 출력
, 5/23 페이지
-
41
- Severity and organ distribution of graft‐versus‐host disease with post‐transplant cyclophosphamide versus calcineurin inhibitor plus methotrexate/mycophenolate mofetil or sirolimus in allogenic HLA‐matched or single‐allele mismatched stem cell transplantation
- Redondo, Sara; Garcí a‐ Cadenas, Irene; Esquirol, Albert; Portos, J. M.; Iranzo, Eva; Arguello‐ Tomas, Miguel; Saavedra, Silvana; Oñ ate, Guadalupe; Caballero, Ana‐ Carolina; Garrido, Ana; Ló pez, Jordi; Muntañ ola, Ana; Paviglianiti, Annalisa; Miqueleiz, Sara; Sierra, Jorge; Briones, Javier; Martino, Rodrigo; Hematology Department, Hospital de la Santa Creu i Sant Pau IIB‐ Sant Pau and José Carreras Leukemia Research Institutes Barcelona Spain; Hematology Department, Hospital de la Santa Creu i Sant Pau IIB‐ Sant Pau and José Carreras Leukemia Research Institutes Barcelona Spain; Hematology Department, Hospital de la Santa Creu i Sant Pau IIB‐ Sant Pau and José Carreras Leukemia Research Institutes Barcelona Spain; Hematology Department, Hospital de la Santa Creu i Sant Pau IIB‐ Sant Pau and José Carreras Leukemia Research Institutes Barcelona Spain; Hematology Department, Hospital de la Santa Creu i Sant Pau IIB‐ Sant Pau and José Carreras Leukemia Research Institutes Barcelona Spain; Hematology Department, Hospital de la Santa Creu i Sant Pau IIB‐ Sant Pau and José Carreras Leukemia Research Institutes Barcelona Spain; Hematology Department, Hospital de la Santa Creu i Sant Pau IIB‐ Sant Pau and Jos&; (European journal of haematology, v.113, 2024, pp.776-787)
-
42
- Predictive factors for poor peripheral blood stem cell mobilization and peak CD34<sup>+</sup>cell count to guide pre-emptive or immediate rescue mobilization
- Sancho, Juan-Manuel; Morgades, Mireia; Grifols, Joan-Ramon; Juncà , Jordi; Guardia, Ramon; Vives, Susana; Ferrà , Christelle; Batlle, Monsterrat; Ester, Anna; Gallardo, David; Millà , Fuensanta; Feliu, Evarist; Ribera, Josep-Maria; Clinical Hematology Department, ICO-Hospital Universitari Germans Trias i Pujol, José Carreras Leukemia Research Institute, Universitat Autò noma de Barcelona, Barcelona, Spain; Clinical Hematology Department, ICO-Hospital Universitari Germans Trias i Pujol, José Carreras Leukemia Research Institute, Universitat Autò noma de Barcelona, Barcelona, Spain; Banc de Sang i Teixits, Badalona, Spain; Clinical Hematology Department, ICO-Hospital Universitari Germans Trias i Pujol, José Carreras Leukemia Research Institute, Universitat Autò noma de Barcelona, Barcelona, Spain; Hematology Department, ICO-Hospital Josep Trueta, Girona, Spain; Clinical Hematology Department, ICO-Hospital Universitari Germans Trias i Pujol, José Carreras Leukemia Research Institute, Universitat Autò noma de Barcelona, Barcelona, Spain; Clinical Hematology Department, ICO-Hospital Universitari Germans Trias i Pujol, José Carreras Leukemia Research Inst; (Cytotherapy : official journal of the International Society for Hematotherapy and Graft Engineering, v.14, 2012, pp.823-829)
-
43
- GMP‐grade CD34<sup>+</sup> selection from HLA‐homozygous licensed cord blood units and short‐term expansion under European ATMP regulations
- Liedtke, Stefanie; Korschgen, Lutz; Korn, Janine; Duppers, Almuth; Kogler, Gesine; Institute of Transplantation Diagnostics and Cell Therapeutics, José Carreras Stem Cell Bank, University Clinic, Heinrich‐ Heine‐ University Dü sseldorf, Dü sseldorf, Germany; Institute of Transplantation Diagnostics and Cell Therapeutics, José Carreras Stem Cell Bank, University Clinic, Heinrich‐ Heine‐ University Dü sseldorf, Dü sseldorf, Germany; Institute of Transplantation Diagnostics and Cell Therapeutics, José Carreras Stem Cell Bank, University Clinic, Heinrich‐ Heine‐ University Dü sseldorf, Dü sseldorf, Germany; Institute of Transplantation Diagnostics and Cell Therapeutics, José Carreras Stem Cell Bank, University Clinic, Heinrich‐ Heine‐ University Dü sseldorf, Dü sseldorf, Germany; Institute of Transplantation Dia; (Vox sanguinis, v.116, 2021, pp.123-135)
-
44
- B‐cell receptors of EBV‐negative Burkitt lymphoma bind modified isoforms of autoantigens
- Bock, Theresa; Bewarder, Moritz; Cetin, Onur; Fadle, Natalie; Regitz, Evi; Schwarz, Eva C.; Held, Jana; Roth, Sophie; Lohse, Stefan; Pfuhl, Thorsten; Wagener, Rabea; Smola, Sigrun; Becker, Sö ren L.; Bohle, Rainer Maria; Trü mper, Lorenz; Siebert, Reiner; Hansmann, Martin‐ Leo; Pfreundschuh, Michael; Drexler, Hans G.; Hoth, Markus; Kubuschok, Boris; Roemer, Klaus; Preuss, Klaus‐ Dieter; Hartmann, Sylvia; Thurner, Lorenz; Department of Internal Medicine I and José Carreras Center for Immuno‐ and Gene Therapy Saarland University Medical School Homburg/Saar Germany; Department of Internal Medicine I and José Carreras Center for Immuno‐ and Gene Therapy Saarland University Medical School Homburg/Saar Germany; Department of Internal Medicine I and José Carreras Center for Immuno‐ and Gene Therapy Saarland University Medical School Homburg/Saar Germany; Department of Internal Medicine I and José Carreras Center for Immuno‐ and Gene Therapy Saarland University Medical School Homburg/Saar Germany; Department of Internal Medicine I and José Carreras Center for Immuno‐ and Gene Therapy Saarland University Medical School Homburg/Saar Germany; Center for Integrative Physiology and Molecular Medicine (CI; (Ejhaem, v.3, 2022, pp.739-747)
-
45
- BAR-Bodies: B-Cell Receptor Antigens As the Targeting Moiety of Antibodies in Substitution for the Variable Region of Heavy and Light Chains
- Bewarder, Moritz; Thurner, Lorenz; Neumann, Frank; Fadle, Natalie; Regitz, Evi; Kemele, Maria; Will, Helene; Goerens, Lisa; Christofyllakis, Konstantinos; Kaddu-Mulindwa, Dominic; Stilgenbauer, Stephan; Kiefer, Maximilian; Preuss, Klaus Dieter; Department of hematology, oncology and rheumatology and José Carreras Center for Immuno and Gene therapy, Saarland University Medical School, Homburg/Saar, Germany; Department of hematology, oncology and rheumatology and José Carreras Center for Immuno and Gene therapy, Saarland University Medical School, Homburg/Saar, Germany; Jose Carreras Center for Immuno- and Gene Therapy, Saarland University Medical School, Homburg, Germany; Department of hematology, oncology and rheumatology and José Carreras Center for Immuno and Gene therapy, Saarland University Medical School, Homburg/Saar, Germany; Jose Carreras Center for Immuno- and Gene Therapy, Saarland University Medical School, Homburg, Germany; Department of hematology, oncology and rheumatology and José Carreras Center for Immuno and Gene therapy, Saarland University Medical School, Homburg/Saar, Germany; Jose Carreras Center for Immuno- and Gene Therapy, Saarland University Medical School, Homburg,; (Blood, v.132, 2018, pp.2940-2940)
-
46
- Reply to Schuster et al
- Schmid, C; Kolb, H-J; 1Department of Medicine III, José Carreras Unit for Hematopoietic Transplantation, Klinikum der Ludwig Maximilians-Universitä t Mü nchen, Munich, Germany; 1Department of Medicine III, José Carreras Unit for Hematopoietic Transplantation, Klinikum der Ludwig Maximilians-Universitä t Mü nchen, Munich, Germany; (Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K, v.19, 2005, pp.1275-1276)
-
47
- Impact of Epstein Barr virus-related complications after high-risk allo-SCT in the era of pre-emptive rituximab
- Garcí a-Cadenas, I; Castillo, N; Martino, R; Barba, P; Esquirol, A; Novelli, S; Orti, G; Garrido, A; Saavedra, S; Moreno, C; Granell, M; Briones, J; Brunet, S; Navarro, F; Ruiz, I; Rabella, N; Valcá rcel, D; Sierra, J; Hospital de la Santa Creu i Sant Pau, José Carreras Leukemia Research Institute, IIB Sant Pau, Universitat Autò noma de Barcelona, Barcelona, Spain; Hospital Vall d’Hebró n, Universitat Autò noma de Barcelona, Barcelona, Spain; Hospital de la Santa Creu i Sant Pau, José Carreras Leukemia Research Institute, IIB Sant Pau, Universitat Autò noma de Barcelona, Barcelona, Spain; Hospital Vall d’Hebró n, Universitat Autò noma de Barcelona, Barcelona, Spain; Hospital de la Santa Creu i Sant Pau, José Carreras Leukemia Research Institute, IIB Sant Pau, Universitat Autò noma de Barcelona, Barcelona, Spain; Hospital de la Santa Creu i Sant Pau, José Carreras Leukemia Research Institute, IIB Sant Pau, Universitat Autò noma de Barcelona, Barcelona, Spain; Hospital Vall d’Hebró n, Universitat Autò noma de Barcelona, Barcelona, Spain; Hospital de la Santa Creu i Sant Pau, José Carreras Leukemi; (Bone marrow transplantation, v.50, 2015, pp.579-584)
-
48
- Prevalence of Anti-Citrullinated Protein Antibodies (ACPA) in Patients with Diffuse Large B-Cell Lymphoma (DLBCL): A Case-Control Study
- Assmann, Gunter; Shihadeh, Klara; Poeschel, Viola; Murawski, Niels; Conigliarou, Jutta; Ong, Mei Fang; Pfreundschuh, Michael; Department of Internal Medicine I, José -Carreras-Centre for Immuno- and Gene Therapy, University Medical School of Saarland, Homburg/Saar, Germany; Department of Internal Medicine, General Hospital of Herrenberg, Esslingen-Herrenberg, Germany; Department of Internal Medicine I, José -Carreras-Centre for Immuno- and Gene Therapy, University Medical School of Saarland, Homburg/Saar, Germany; Department of Internal Medicine I, José -Carreras-Centre for Immuno- and Gene Therapy, University Medical School of Saarland, Homburg/Saar, Germany; Department of Internal Medicine I, José -Carreras-Centre for Immuno- and Gene Therapy, University Medical School of Saarland, Homburg/Saar, Germany; Institute of Medical Biometry, Epidemiology and Medical Informatics, Saarland University, Homburg/Saar, Germany; Department of Internal Medicine I, José -Carreras-Centre for Immuno- and Gene Therapy, University Medical School of Saarland, Homburg/Saar, Germany; (PloS one, v.9, 2014, pp.e88177)
-
49
- Progranulin antibodies entertain a proinflammatory environment in a subgroup of patients with psoriatic arthritis
- Thurner, Lorenz; Zaks, Marina; Preuss, Klaus-Dieter; Fadle, Natalie; Regitz, Evi; Ong, Mei Fang; Pfreundschuh, Michael; Assmann, Gunter; Department of Internal Medicine I, José Carreras-Center for Immuno- and Gene Therapy, University of Saarland Medical School, Kirrbergerstr., D-66421 Homburg, Saar, Germany; Department of Internal Medicine I, José Carreras-Center for Immuno- and Gene Therapy, University of Saarland Medical School, Kirrbergerstr., D-66421 Homburg, Saar, Germany; Department of Internal Medicine I, José Carreras-Center for Immuno- and Gene Therapy, University of Saarland Medical School, Kirrbergerstr., D-66421 Homburg, Saar, Germany; Department of Internal Medicine I, José Carreras-Center for Immuno- and Gene Therapy, University of Saarland Medical School, Kirrbergerstr., D-66421 Homburg, Saar, Germany; Department of Internal Medicine I, José Carreras-Center for Immuno- and Gene Therapy, University of Saarland Medical School, Kirrbergerstr., D-66421 Homburg, Saar, Germany; Institute of Medical Biostatistics, Saarland University, Kirrbergerstr., D-66421 Homburg, Saar,; (Arthritis research & therapy, v.15, 2013, pp.R211-R211)
-
50
- LRPAP1 Is a Frequent B-Cell Receptor Antigen in Mantle Cell Lymphoma (MCL)
- Thurner, Lorenz; Hartmann, Sylvia; Preuss, Klaus-Dieter; Fadle, Natalie; Kemele, Maria; Regitz, Evi; Pott, Christiane; Bohle, Rainer-Maria; Hansmann, Martin-Leo; Pfreundschuh, Michael; José Carreras Center for Immuno- and Gene Therapy and Internal Medicine I, Saarland University Medical School, Homburg/Saar, Germany; Dr. Senckenberg Institute of Pathology, Goethe University Hospital of Frankfurt Main, Frankfurt am Main, Germany; José Carreras Center for Immuno- and Gene Therapy and Internal Medicine I, Saarland University Medical School, Homburg, Germany; José Carreras Center for Immuno- and Gene Therapy and Internal Medicine I, Saarland University Medical School, Homburg/Saar, Germany; José Carreras Center for Immuno- and Gene Therapy and Internal Medicine I, Saarland University Medical School, Homburg/Saar, Germany; José Carreras Center for Immuno- and Gene Therapy and Internal Medicine I, Saarland University Medical School, Homburg/Saar, Germany; University Hospital Schleswig-Holstein, Kiel, Germany; Institute of Pathology, Saarland University Medical School, Homburg/Saar, Germany; Dr. Senckenberg Institute of Pathology,; (Blood, v.126, 2015, pp.2685-2685)
QUICK MENU
